Reproductive · PANCE / PANRE

Secondary Amenorrhea

Absence of menses for ≥3 months (regular cycles) or ≥6 months (irregular cycles) in a previously menstruating woman.

Also known as: secondary amenorrhea, missed menses, absent menses

Overview

Cessation of menstruation for at least 3 consecutive months in a woman with previously regular cycles, or 6 months in a woman with previously irregular cycles.

Epidemiology

Affects ~3-4% of reproductive-age women. Pregnancy is by far the most common cause; pathologic causes include PCOS (most common pathologic), hypothalamic amenorrhea, hyperprolactinemia, thyroid disease, and primary ovarian insufficiency.

Try two board-style Secondary Amenorrhea questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1EndocrineMedium
A 35-year-old female has 6 months of amenorrhea, vaginal dryness, hot flashes, and mood changes. Follicle-stimulating hormone (FSH) is 78 IU/L, luteinizing hormone (LH) is 52 IU/L, and estradiol is 18 pg/mL. Anti-ovarian antibodies are positive. Which of the following is the most likely diagnosis?
  • AAsherman syndrome
  • BHyperprolactinemia
  • CPolycystic ovary syndrome
  • DHypothalamic amenorrhea
  • EPrimary ovarian insufficiency
Reveal answer & full explanation
Correct answer: E — Primary ovarian insufficiency
  • AAsherman syndrome
  • BHyperprolactinemia
  • CPolycystic ovary syndrome
  • DHypothalamic amenorrhea
  • EPrimary ovarian insufficiency✓

Why Primary ovarian insufficiency is correct

  • Primary ovarian insufficiency (POI) is defined as follicle-stimulating hormone (FSH) >25 IU/L on two occasions ≥4 weeks apart before age 40, with menstrual irregularity.
  • High follicle-stimulating hormone (FSH)/luteinizing hormone (LH) plus low estrogen = hypergonadotropic hypogonadism.
  • Distinguish from hypothalamic amenorrhea: low FSH/LH plus low estrogen (hypogonadotropic hypogonadism).
  • Anti-ovarian antibodies suggest an autoimmune etiology.
  • Treatment: hormone replacement therapy (HRT) until average menopausal age (51) to prevent osteoporosis, cardiovascular disease, and cognitive decline.
  • Spontaneous pregnancy remains possible in 5–10% of cases.

Why the others are wrong

  • Asherman syndrome — intrauterine adhesions (usually post-instrumentation) cause amenorrhea with normal FSH/LH and estradiol, and produce no hot flashes or vaginal dryness since estrogen is preserved.
  • Polycystic ovary syndrome — presents with oligomenorrhea plus hyperandrogenism and an elevated LH:FSH ratio with normal or high estradiol, not the high FSH/LH with low estrogen and hypoestrogenic symptoms seen here.
  • Hypothalamic amenorrhea — causes hypogonadotropic hypogonadism with low FSH/LH and low estradiol, the opposite of the markedly elevated gonadotropins in this patient.
  • Hyperprolactinemia — a common, treatable cause of secondary amenorrhea with hypoestrogenic symptoms, but elevated prolactin suppresses GnRH pulsatility and yields low or inappropriately normal FSH/LH, not the markedly elevated gonadotropins seen here; it often causes galactorrhea and is screened for with a serum prolactin level in the amenorrhea workup.
Question 2ReproductiveMedium
A 29-year-old woman has secondary amenorrhea. Pregnancy test is negative. TSH is normal and prolactin is elevated. Which of the following symptoms is most likely associated?
  • APurple abdominal striae
  • BAcanthosis nigricans
  • CBilateral galactorrhea
  • DRecurrent hot flashes
  • ECoarse facial hirsutism
Reveal answer & full explanation
Correct answer: C — Bilateral galactorrhea
  • APurple abdominal striae
  • BAcanthosis nigricans
  • CBilateral galactorrhea✓
  • DRecurrent hot flashes
  • ECoarse facial hirsutism

Why Bilateral galactorrhea is correct

  • Elevated prolactin suppresses GnRH, lowering LH and FSH, which explains the secondary amenorrhea.
  • Prolactin directly stimulates breast milk production, so galactorrhea is the classic accompanying sign of hyperprolactinemia.
  • A normal TSH excludes hypothyroidism as the driver, isolating prolactin excess as the cause.

Why the others are wrong

  • Recurrent hot flashes — point to estrogen deficiency from primary ovarian insufficiency or menopause, not prolactin excess (amenorrhea-cause trap).
  • Coarse facial hirsutism — reflects androgen excess such as PCOS; prolactin elevation does not virilize.
  • Acanthosis nigricans — is a cutaneous marker of insulin resistance seen with PCOS-related anovulation; prolactin excess does not produce it.
  • Purple abdominal striae — Cushing syndrome is another endocrine cause of secondary amenorrhea, but there cortisol excess suppresses gonadotropin secretion without raising prolactin, so striae point away from the hyperprolactinemia found here.

That's 2. Get 7,700+ more.

Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial →
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Secondary Amenorrhea outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Recent pregnancy or breastfeeding
  • Significant weight loss, low BMI, eating disorder
  • Excessive exercise (endurance athletes, dancers)
  • Major psychological stress
  • Antipsychotics, opioids, hormonal contraceptives
  • Intrauterine instrumentation (Asherman syndrome)
  • Family history of premature ovarian insufficiency

Pathophysiology

Menstruation requires cyclic ovarian estrogen/progesterone production with intact endometrial responsiveness and patent outflow. Common pathways: hypothalamic suppression (energy deficit, stress), pituitary lesions (prolactinoma), ovarian failure (POI, chemo/radiation), endometrial damage (Asherman from D&C, infection), and androgen excess (PCOS) producing anovulation.

Clinical presentation

Symptoms

  • Cessation of menses
  • Symptoms of underlying cause: galactorrhea (prolactinoma), hot flashes (POI/menopause), hirsutism (PCOS), heat/cold intolerance (thyroid), weight changes
  • Cyclic pelvic pain may suggest outflow obstruction (cervical stenosis post-procedure)

Signs / physical exam

  • BMI, vital signs
  • Visual field testing if pituitary lesion suspected
  • Thyroid exam, breast exam (galactorrhea)
  • Pelvic exam: vaginal atrophy (low estrogen), uterine size, adnexal masses
  • Skin: acanthosis nigricans, hirsutism, acne, striae

Differential diagnosis

  • Pregnancy — Most common cause; always check hCG
  • PCOS — Hyperandrogenism + chronic anovulation
  • Functional hypothalamic amenorrhea — Low weight, exercise, stress; low FSH/LH/estradiol
  • Hyperprolactinemia — Galactorrhea; check medications, pregnancy, TSH; pituitary MRI
  • Thyroid disease — Hypo- or hyperthyroid symptoms; abnormal TSH
  • Primary ovarian insufficiency — Hot flashes, vaginal dryness <40 yo; FSH >25 IU/L (a single elevated value suffices)
  • Asherman syndrome — Amenorrhea or hypomenorrhea after D&C, endometritis, or uterine surgery; absent withdrawal bleed; hysteroscopy diagnostic
  • Cushing syndrome / hyperandrogenism (CAH, tumor) — Virilization, central obesity, striae; specific endocrine testing

Diagnostic workup

Diagnostic criteria

Progesterone challenge test (medroxyprogesterone 10 mg × 10 days) can assess estrogen status: bleeding suggests adequate estrogen + patent outflow (anovulation pattern); no bleeding suggests low estrogen OR outflow obstruction OR endometrial unresponsiveness — confirm with estrogen-progestin challenge.

Labs

  • Pregnancy test (urine or serum hCG) — always first
  • TSH and prolactin
  • FSH (high → POI; low/normal → central or PCOS)
  • If hyperandrogenism: total testosterone, DHEAS, 17-OHP
  • Estradiol if FSH abnormal

Imaging

  • Pelvic ultrasound if structural cause suspected
  • Brain MRI (pituitary protocol) for elevated prolactin or hypogonadotropic hypogonadism
  • Hysteroscopy or saline sonohysterography if Asherman suspected (history of D&C, endometritis)

Diagnostic algorithm

flowchart TD
  A[Secondary amenorrhea] --> B[hCG]
  B -->|Positive| C[Pregnancy]
  B -->|Negative| D[TSH, prolactin]
  D -->|High prolactin| E[Pituitary MRI<br/>Dopamine agonist]
  D -->|Abnormal TSH| F[Thyroid treatment]
  D -->|Normal| G[FSH, estradiol]
  G -->|High FSH| H["Primary ovarian insufficiency<br/>FSH >25 IU/L; repeat in 4-6 wk<br/>only if uncertain"]
  G -->|Low/normal FSH| I{Hyperandrogenism?}
  I -->|Yes| J[PCOS workup]
  I -->|No| K[Progesterone challenge]
  K -->|Withdrawal bleed| L["Adequate estrogen with anovulation<br/>(e.g., PCOS)"]
  K -->|No bleed| M["E+P challenge"]
  M -->|Bleed| N["Hypoestrogenism, patent outflow:<br/>functional hypothalamic amenorrhea,<br/>hypothalamic-pituitary cause"]
  M -->|No bleed| O["Outflow or endometrial cause:<br/>Asherman syndrome"]
Algorithm for secondary amenorrhea — pregnancy first, then TSH/prolactin/FSH stratify.

Treatment

First-line

  • Treat the underlying cause
  • Pregnancy: prenatal care
  • PCOS: see PCOS entry — COCP or cyclic progestin
  • Functional hypothalamic amenorrhea: nutritional restoration, reduce exercise, address stress; CBT for those with eating disorder
  • Hyperprolactinemia: dopamine agonists (cabergoline preferred, bromocriptine alternative)
  • Thyroid disease: levothyroxine or antithyroid therapy
  • POI: hormone therapy (estrogen + progestin) until average age of menopause

Asherman syndrome

  • Hysteroscopic lysis of adhesions
  • Postoperative estrogen to promote endometrial regrowth
  • Intrauterine device or balloon to prevent re-adhesion

Premature ovarian insufficiency

  • Hormone replacement until ~age 51 (mean menopause age)
  • Calcium and vitamin D
  • Fertility counseling — pregnancy possible with donor oocytes
  • Screen for autoimmune comorbidities (adrenal, thyroid)

Complications

  • Infertility
  • Osteoporosis from prolonged hypoestrogenism
  • Endometrial hyperplasia from unopposed estrogen (PCOS, obesity)
  • Cardiovascular risk in untreated POI
  • Psychological distress

PANCE pearls

  • Always rule out pregnancy first — even with denied sexual activity, contraception use, or recent menses.
  • Functional hypothalamic amenorrhea is a diagnosis of exclusion; first restore energy availability before starting hormone therapy.
  • Hyperprolactinemia from medications (antipsychotics, metoclopramide, opioids) usually causes prolactin <100 ng/mL; tumors cause higher levels.
  • POI is diagnosed in a woman under 40 with at least 4 months of oligo/amenorrhea and a single FSH >25 IU/L; repeat FSH in 4-6 weeks only if the diagnosis is uncertain (2024 ESHRE/ASRM POI guideline).
  • A withdrawal bleed after progesterone challenge implies adequate endogenous estrogen — proceed with workup for anovulation, not POI.

References

  • ACOG CO 605 — ACOG Committee Opinion 605: Primary Ovarian Insufficiency in Adolescents and Young Women
  • Endocrine Society 2017 — Functional Hypothalamic Amenorrhea: Endocrine Society Clinical Practice Guideline (Gordon et al., JCEM 2017)
  • Endocrine Society 2011 — Diagnosis and Treatment of Hyperprolactinemia: Endocrine Society Clinical Practice Guideline (Melmed et al., JCEM 2011)
  • ESHRE/ASRM/CRE-WHiRL/IMS 2024 — Panay N, Anderson RA, et al. Evidence-based guideline: premature ovarian insufficiency. Hum Reprod Open 2024;2024(4):hoae065; co-published Fertil Steril 2025;123(2):221-236

Practice Reproductive questions on FirstPassPA

Turn this outline into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start your 7-day free trial → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.